Vonova
San Diego
About Vonova
Vonova is developing a breakthrough catheter platform as the first alternative to drilling through the skull for the $2B+ brain interface market’a broad category of interventions addressing chronic neurological disorders with cortical electrodes for both recording and stimulating. The company's flagship product, the Cerebro Atlas System, will provide neuromodulation therapy for drug-resistant chronic pain without the high risk and discomfort associated with invasive brain surgery. Founded in 2022 by a management team with expertise in catheter device development and neurology, Vonova has issued US patents, demonstrated the procedure's feasibility with clinical key opinion leaders, and received an NIH Blueprint Seed Award. Vonova has also been selected from over 1300 medtech companies to participate in the MedTech Innovator cohort 2024 and accelerate the commercial strategy with a wide network of strategic partners.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Pre-Seed (Aug 2024)
- Website: vonova.io
Industries & Categories
Biotechnology, Human Computer Interaction, Medical Device, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/vonova-2213063 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.